Status:
COMPLETED
Genetic Counseling in African American Women
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
United States Department of Defense
Conditions:
Breast Cancer
Ovarian Cancer
Eligibility:
FEMALE
18-85 years
Phase:
NA
Brief Summary
The objectives of this study are to develop a Culturally Tailored Genetic (CTGC) protocol for African American women and evaluate its impact on decision making and satisfaction about BRCA1/2 testing, ...
Detailed Description
Five to 10% of all breast cancer cases have been attributed to two breast ovarian cancer susceptibility genes called BRCA1 and BRCA2 (BRCA1/2). Genetic counseling and testing for BRCA1/2 mutations is ...
Eligibility Criteria
Inclusion
- Female
- African American or Black
- 5% to 10% prior probability of having a BRCA1 or BRCA2 mutation
Exclusion
- Men
- Individuals who are not African American or Black
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT00419510
Start Date
February 1 2003
End Date
September 1 2012
Last Update
August 17 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104